Alexion Pharmaceuticals Inc.

Alexion Pharmaceuticals Inc. Stock

58.82P/E
€34.24BMarket capitalisation
US$3.08Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.

Alexion Pharmaceuticals Inc. is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Alexion Pharmaceuticals Inc. stock.

Market capitalisation
€34.24B
P/E
58.82
P/B
3.24
P/S
6.44
P/CF
13.07
Issued shares 221M Units

Return

Here you can see the performance of the Alexion Pharmaceuticals Inc. stock.

PeriodPerfor­mance
1 Week+72.93 %
1 Month+81.51 %
3 Months+1.80 %
6 Months+20.06 %
1 Year+31.45 %
YTD+23.62 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Alexion Pharmaceuticals Inc. share.

DateRatio
23.05.20111:0.5
25.08.20082:1

Which ETF contains the Alexion Pharmaceuticals Inc. stock?

The Alexion Pharmaceuticals Inc. stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Alexion Pharmaceuticals Inc. has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Alexion Pharmaceuticals Inc. stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.